Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa

BACKGROUND: Mortality from cryptoccocal meningitis remains high. The ACTA trial demonstrated that, compared with 2 weeks of amphotericin B (AmB) plus flucystosine (5FC), 1 week of AmB and 5FC was associated with lower mortality and 2 weeks of oral flucanozole (FLU) plus 5FC was non-inferior. Here, w...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Infect Dis
Главные авторы: Chen, Tao, Mwenge, Lawrence, Lakhi, Shabir, Chanda, Duncan, Mwaba, Peter, Molloy, Síle F, Gheorghe, Adrian, Griffiths, Ulla K, Heyderman, Robert S, Kanyama, Cecilia, Kouanfack, Charles, Mfinanga, Sayoki, Chan, Adrienne K, Temfack, Elvis, Kivuyo, Sokoine, Hosseinipour, Mina C, Lortholary, Olivier, Loyse, Angela, Jaffar, Shabbar, Harrison, Thomas S, Niessen, Louis W
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2019
Предметы:
Articles and Commentaries
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6669289/
https://ncbi.nlm.nih.gov/pubmed/30863852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy971
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы